PY-159 | m-entrepreneurship.com

Product Name :
PY-159

Search keywords :
PY159

drugId :
null

Target Vo:
Triggering receptor expressed on myeloid cells 1

Target Vo Short Name :
TREM1

Moa_Name:
Triggering receptor expressed on myeloid cells 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Centre for the Commercialization of Antibodies and Biologics

Active Company_Name :
Pionyr Immunotherapeutics Inc

Active Indication_Name:
Solid tumours

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Nab-Paclitaxel Protocol
Pertuzumab Autophagy
PAX6 Antibody: PAX6 Antibody is an antibody targeting to PAX6.

Author: Betaine hydrochloride

Related Posts